PT  - JOURNAL ARTICLE
AU  - Mbarek, Hamdi
AU  - Cocca, Massimiliano
AU  - Al Sarraj, Yasser
AU  - Saad, Chadi
AU  - Mezzavilla, Massimo
AU  - AlMuftah, Wadha
AU  - Cocciadiferro, Dario
AU  - Novelli, Antonio
AU  - Quinti, Isabella
AU  - AlTawashi, Azza
AU  - Salvaggio, Salvino
AU  - AlThani, Asma
AU  - Novelli, Giuseppe
AU  - Ismail, Said
TI  - Poking COVID-19: insights on genomic constraints among immune-related genes between Qatari and Italian populations
AID  - 10.1101/2021.10.04.21264507
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.04.21264507
4099  - http://medrxiv.org/content/early/2021/10/08/2021.10.04.21264507.short
4100  - http://medrxiv.org/content/early/2021/10/08/2021.10.04.21264507.full
AB  - Host genomic information, specifically genomic variations, may characterize susceptibility to disease and identify people with a higher risk of harm, leading to better targeting of care and vaccination. Italy was the epicentre for the spread of COVID-19 in Europe, the first country to go into a national lockdown and has one of the highest COVID-19 associated mortality rates. Qatar, on the other hand has a very low mortality rate. In this study, we compared whole-genome sequencing data of 14398 adults and Qatari-national to 925 Italian individuals. We also included in the comparison whole-exome sequence data from 189 Italian laboratory confirmed COVID-19 cases. We focused our study on a curated list of 3619 candidate genes involved in innate immunity and host-pathogen interaction. Two population-gene metric scores, the Delta Singleton-Cohort variant score (DSC) and Sum Singleton-Cohort variant score (SSC), were applied to estimate the presence of selective constraints in the Qatari population and in the Italian cohorts. Results based on DSC SSC metrics demonstrated a different selective pressure on three genes (MUC5AC, ABCA7, FLNA) between Qatari and Italian populations. This study highlighted the genetic differences between Qatari and Italian populations and identified a subset of genes involved in innate immunity and host-pathogen interaction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was also supported in part by a grant of Regione Lazio (Italy, Progetti di Gruppi di Ricerca 2020 A0375-2020-36663 GecoBiomark) to G.N. and A.N. and Rome Foundation (Italy, Prot 317A/I) to GN.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The recruitment and sequencing of participants from the Qatar Biobank (QBB) were approved by the Hamad Medical Corporation Ethics Committee in 2011 and continued with QBB IRB from 2017 onwards and renewed annually (protocol IRB-A-QBB-2019-0017). The genetic analyses were approved by the QBB IRB protocol E-2020-QBB-Res-ACC-0226-0130I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccess to the QGP data used for this study is through a dedicated portal by QGP (Accession ID: QF-QGP-RES-PUB-0226). The informed consent given by the study participants does not cover posting of participant level phenotype and genotype data of Qatar Biobank (QBB)/Qatar Genome Project (QGP) in public databases. Access to QBB/QGP data can be obtained through an established ISO-certified process by submitting a project request at https://www.qatarbiobank.org.qa/research/ how-apply which is subject to approval by the QBB IRB committee. The genetic data belonging to INGI cohorts and analyzed in this manuscript have been submitted to the European Variation Archive (EVA) are accessible in Variant Call Format (VCF) at the following link: https://www.ebi.ac.uk/ena/data/view/PRJEB33648